ARTHUR T. SANDS, M.D., PH.D. FOR LEXICON GENETICS

Company

LEXICON PHARMACEUTICALS, INC.

Filed

February 9, 2001

Accession Number

0000950129-01-000657

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →